DE69905191T2 - Kondensierte pyridazinonverbindungen - Google Patents

Kondensierte pyridazinonverbindungen

Info

Publication number
DE69905191T2
DE69905191T2 DE69905191T DE69905191T DE69905191T2 DE 69905191 T2 DE69905191 T2 DE 69905191T2 DE 69905191 T DE69905191 T DE 69905191T DE 69905191 T DE69905191 T DE 69905191T DE 69905191 T2 DE69905191 T2 DE 69905191T2
Authority
DE
Germany
Prior art keywords
group
stands
formula
alkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69905191T
Other languages
English (en)
Other versions
DE69905191D1 (de
Inventor
Ferenc Andrasi
Agnes Angyal
Pal Berzsenyi
Sandor Boros
Laszlo Harsing
Katalin Horvath
Peter Matyus
Imre Moravcsik
Agnes Papp
Antal Simay
Erzsebet Szabo
Katalin Szabo
Istvan Tarnawa
Ildiko Varga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Hungary Pharmaceutical Marketing PLC
Original Assignee
Institute for Drugs Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute for Drugs Research Ltd filed Critical Institute for Drugs Research Ltd
Publication of DE69905191D1 publication Critical patent/DE69905191D1/de
Application granted granted Critical
Publication of DE69905191T2 publication Critical patent/DE69905191T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69905191T 1998-11-09 1999-11-09 Kondensierte pyridazinonverbindungen Expired - Fee Related DE69905191T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9802585A HUP9802585A3 (en) 1998-11-09 1998-11-09 Pyridazinooxazepine, -thiazepine, -diazepine and thiazine derivatives and pharmaceutical compositions containing them
PCT/HU1999/000077 WO2000027851A1 (en) 1998-11-09 1999-11-09 Novel type condensed pyridazinone compounds

Publications (2)

Publication Number Publication Date
DE69905191D1 DE69905191D1 (de) 2003-03-06
DE69905191T2 true DE69905191T2 (de) 2003-10-16

Family

ID=89997316

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69905191T Expired - Fee Related DE69905191T2 (de) 1998-11-09 1999-11-09 Kondensierte pyridazinonverbindungen

Country Status (12)

Country Link
EP (1) EP1129097B1 (de)
JP (1) JP2002529470A (de)
KR (1) KR100636515B1 (de)
AT (1) ATE231873T1 (de)
AU (1) AU762526B2 (de)
CA (1) CA2350560C (de)
DE (1) DE69905191T2 (de)
DK (1) DK1129097T3 (de)
ES (1) ES2192104T3 (de)
HU (1) HUP9802585A3 (de)
PT (1) PT1129097E (de)
WO (1) WO2000027851A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0405034D0 (en) * 2004-03-05 2004-04-07 Novartis Ag Organic compounds
AU2009274255A1 (en) 2008-07-23 2010-01-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inhibitors of the plasmodial surface anion channel as antimalarials
WO2012142125A2 (en) 2011-04-12 2012-10-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411955D0 (en) * 1994-06-15 1994-08-03 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
DE69905191D1 (de) 2003-03-06
KR20010092424A (ko) 2001-10-24
EP1129097A1 (de) 2001-09-05
PT1129097E (pt) 2003-06-30
ES2192104T3 (es) 2003-09-16
HUP9802585A2 (hu) 2000-08-28
WO2000027851A1 (en) 2000-05-18
JP2002529470A (ja) 2002-09-10
AU762526B2 (en) 2003-06-26
EP1129097B1 (de) 2003-01-29
AU1401600A (en) 2000-05-29
HU9802585D0 (en) 1999-01-28
KR100636515B1 (ko) 2006-10-18
HUP9802585A3 (en) 2000-09-28
CA2350560A1 (en) 2000-05-18
CA2350560C (en) 2006-10-31
ATE231873T1 (de) 2003-02-15
DK1129097T3 (da) 2003-06-02

Similar Documents

Publication Publication Date Title
HUP0302943A2 (hu) Új heterociklusos vegyületek, előállításuk és alkalmazásuk gyógyszerekként, különösen antibakteriális szerekként
HUP9903707A2 (hu) 17Béta-karboxi-,-tio-karboxi-vagy -amido-androsztánszármazékok laktonszármazékai, előállításuk, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
PT1161428E (pt) Compostos de pirimidina
IE792074L (en) Pyran- and thiopyran-fused heterocyclic compounds
DE60111205D1 (de) Triarylimidazol-derivate als cytokin-inhibitoren
TW200612920A (en) Novel imidazolidine derivatives
MEP7808A (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
TW200730897A (en) Optical film containing polymer having naphthyl group
HUP0003748A2 (hu) Halogén-szubsztituált tetraciklusos tetrahidrofurán-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
DE69925472D1 (de) Benzoheterocyclische distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
TW200505337A (en) Substituted benzoyl derivatives as herbicides
MX9101232A (es) Derivados de benceno,piridina y pirimidina
BR0308759A (pt) Derivados de fenil amidas siliconadas utilizáveis como microbiocida
HRP20070030T3 (en) Derivatives of benzothiazine and benzothiadiazine, procedure for their preparation and pharmaceutical compositions containing them
DE69905191T2 (de) Kondensierte pyridazinonverbindungen
ATE274518T1 (de) 6-(2-chlor-6-fluor-phenyl)-triazolpyrimidine
ATE445619T1 (de) Pyridinylpyrazolopyrimidinon-derivate als pde 7 inhibitoren
MEP12108A (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
DK0695296T3 (da) 3-aryloxycarboxylsyrederivater og fremgangsmåde til fremstilling heraf
GB9812211D0 (en) Cinnamoyl distamycin analogous derivatives,process for their preparation,and their use as antitumor agents
NO20041704L (no) Substituerte alkylaminopyridazinonderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som inneholder disse
ES2058182T3 (es) Analogos de mitomicina. un procedimiento para su preparacion y composiciones farmaceuticas.
DE60239324D1 (de) Phenyl- und pyridyl-piperidine mit tnf-wirkung
TH58475B (th) อนุพันธุ์ของ 1,4-ไดอะซาไบไซโคล [3.2.2]โนเนน-4-คาร์บอกซีเลต และ คาร์บอกซามีด การเตรียมและการใช้รักษาโรค
HUP0201305A2 (hu) 1-[Aril-szulfonil- vagy aril(tio)karbonil]-piridazin-származékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: IVAX DRUG RESEARCH INSTITUTE LTD., BUDAPEST, HU

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee